Global Breast Reconstruction Market, By Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral Breast Reconstruction, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others) - Industry Trends and Forecast to 2031.
Breast Reconstruction Market Analysis and Size
Breast reconstruction is a critical component of the overall treatment and recovery process for individuals who have undergone mastectomy due to breast cancer or other medical conditions. It plays a crucial role in restoring a woman's sense of femininity and body image, positively impacting psychological and emotional well-being. Breast reconstruction contributes to the improvement of the quality of life for women who have experienced breast cancer or trauma. It allows individuals to regain confidence, self-esteem, and a sense of normalcy in their lives.
Data Bridge Market Research analyzes that the global breast reconstruction market, which was USD 492.10 million in 2023, is likely to reach USD 1,051.27 million by 2031 and is expected to undergo a CAGR of 8.8% during the forecast period. “Breast implants” dominate the product segment of the breast reconstruction market due to the growing prevalence of breast surgeries.
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral Breast Reconstruction, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (South Korea), Establishment Labs S.A (Costa Rica), ALLERGAN (Ireland), AbbVie Inc.(U.S.), Johnson & Johnson Services, Inc.(U.S.), GC Aesthetics (Ireland), Arion Laboratories (Canada), IDEAL IMPLANT INCORPORATED (U.S.), Sientra, Inc.(U.S.), HANSBIOMED CO. LTD (South Korea), AirXpanders (U.S.), PMT Corporation (U.S.), Silimed (Brazil), Integra Lifesciences (U.S.), DPS Technology Development Ltd (Hong Kong), Wanhe (China), KOKEN CO., LTD.(Japan), Sebbin (France), DEFYGRAVITY (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Breast reconstruction refers to the surgical procedure or series of procedures that aim to restore the shape, size, symmetry, and appearance of one or both breasts following mastectomy, lumpectomy, or other trauma or congenital abnormalities. The primary goal of breast reconstruction is to recreate a natural-looking breast contour while addressing the physical and psychological impact of breast loss. The decision to undergo breast reconstruction is highly personal and depends on various factors, including the individual's health, preferences, and circumstances. Women who have undergone mastectomy for breast cancer treatment or have a high risk of developing breast cancer may choose breast reconstruction to restore their physical appearance and enhance their overall well-being.
Global Breast Reconstruction Market Dynamics
Drivers
- Rising Incidence of Breast Cancer
The rising incidence of breast cancer globally is a significant driver for the breast reconstruction market. As more women undergo mastectomy as part of their breast cancer treatment, there is an increasing demand for breast reconstruction procedures to restore the physical appearance of the breast, contributing to the growth of the market.
- Advancements in Surgical Techniques and Technologies
Ongoing advancements in surgical techniques and technologies for breast reconstruction, such as the development of more sophisticated implants, autologous tissue reconstruction methods, and innovative surgical tools, drive the market. Patients and surgeons seek procedures that provide improved aesthetics, reduced complications, and faster recovery times.
Opportunity
- Rising Focus on Aesthetic Outcomes
There is a growing emphasis on achieving aesthetically pleasing outcomes in breast reconstruction. Patients often seek procedures that not only restore the breast but also enhance its natural appearance. Advancements in implant technologies and autologous tissue reconstruction contribute to achieving more realistic and satisfying results, creating opportunities for market growth.
Restraint/Challenge
- Limited Access to Reconstructive Procedures
Limited access to breast reconstruction procedures is a significant restraint, particularly in regions with insufficient healthcare infrastructure or disparities in access to healthcare services. Factors such as geographic location, economic conditions, and lack of specialized healthcare facilities can hinder individuals' ability to undergo reconstructive surgery after mastectomy.
Recent Developments
- In April 2023, an Israeli 3D printing company, Stratasys & CollPlant Technologies which is an American bioinks company, are collaborating to create the technology to 3D-print breast implants to aid patients in regenerating their natural breast tissue. The implants are made to replace lost biological breast tissue without triggering an immune reaction. CollPlant has successfully finished a large-animal study for its 3D bio-printed regenerative breast implants, and it intends to start a follow-up study in the second half of 2023 using commercial-size implants to support upcoming human studies
- In October 2022, The LUNA xtTM was the first micro-textured anatomical breast implant to receive CE approval under the European Medical Device Regulation. Luna xtTM is developed by GC Aesthetics, and it offers an industry-leading response to surgeon and patient needs in breast reconstruction procedures
- In August 2022, 3D-printed Scaffolds were created by Australian researchers using additive manufacturing techniques, eventually taking the place of traditional silicone breast implants. The scaffold is made of the same material as dissolvable stitches and resembles a traditional implant. The research group anticipates this technology will transform breast reconstruction and cosmetic surgery procedures
Global Breast Reconstruction Market Scope
The breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Breast Implants
- Tissue Expanders
- Acellular Dermal Matrix
Type
- Unilateral Breast Reconstruction
- Bilateral
Shape
- Round Implants
- Anatomical Implants
Technology
- Inframammary
- Peri-areolar
- Trans-axillary
- Trans-umbilical
Placement
- Dual-Plane Insertion
- Subglandular Insertion
- Submuscular Insertion
Procedure
- Immediate Procedures
- Delayed Procedures
- Revision Procedures
End User
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Others
Global Breast Reconstruction Market Regional Analysis/Insights
The breast reconstruction market is analyzed and market size insights and trends are provided by country, product, type, shape, technology, placement, procedure, and end user as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Brazil, Argentina, rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and rest of Middle East and Africa.
North America is expected to the dominate the market due to the presence of advanced healthcare infrastructure.
Asia-Pacific is expected to be the fastest-growing region in the market due to the rising prevalence of breast cancer.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The breast reconstruction market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the breast reconstruction market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the breast reconstruction market.
Competitive Landscape and Breast Reconstruction Market Share Analysis
The breast reconstruction market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the breast reconstruction market.
Some of the major players operating in the breast reconstruction market are:
- POLYTECH Health & Aesthetics GmbH (Germany)
- CEREPLAS (South Korea)
- Establishment Labs S.A (Costa Rica)
- ALLERGAN (Ireland)
- AbbVie Inc. (U.S.)
- Johnson & Johnson Services, Inc. (U.S.)
- GC Aesthetics (Ireland)
- Arion Laboratories (Canada)
- IDEAL IMPLANT INCORPORATED (U.S.)
- Sientra, Inc. (U.S.)
- HANSBIOMED CO. LTD (South Korea)
- AirXpanders (U.S.)
- PMT Corporation (U.S.)
- Silimed (Brazil)
- Integra Lifesciences (U.S.)
- DPS Technology Development Ltd (Hong Kong)
- Wanhe (China)
- KOKEN CO., LTD.(Japan)
- Sebbin (France)
- DEFYGRAVITY (U.K.)
SKU-